Medical supplies could be held up at border after Brexit, peers hear
BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4640 (Published 01 November 2018) Cite this as: BMJ 2018;363:k4640- Jacqui Wise
- London
Delays at the UK border resulting from a “no deal” Brexit could be a problem for supplies of medical products with a short shelf life, such as radioisotopes and some gene therapies, a House of Lords subcommittee has heard.1
Mark Dayan, policy and public affairs analyst at the health think tank the Nuffield Trust, told peers on the EU Home Affairs Sub-Committee on 31 October, “One of the biggest short term worries about a no deal Brexit for the NHS is the disruption in supplies caused by delays.” The subcommittee is charged with scrutinising proposed EU legislation on home …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.